Colostomy - StomaNCT07206836
Pediatric Colostomy Reversal: Traditional Care vs. Enhanced Recovery After Surgery
A study testing Enhanced Recovery after Surgery Protocol and Traditional Care Protocol in people with Colostomy - Stoma and Stoma Reversal Procedure, run by Children Hospital Faisalabad at 1 site in Pakistan.
Trial summary
The goal of this clinical trial is to learn whether using an Enhanced Recovery After Surgery (ERAS) protocol helps children recover faster after colostomy reversal compared with traditional care. Read more about this study
- Who is it for?
- Ages 2 to 13 years
- Conditions the study is for
- Colostomy - Stoma, Stoma Reversal Procedure, ERAS
- What is being tested?
- Enhanced Recovery after Surgery Protocol and Traditional Care Protocol
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Aug 2025to Nov 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 13 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Patients with Colostomy
- Admitted for Reversal of colostomy
Who cannot join
- Patients with endocrinal abnormalities
- Patients with cardiac abnormalities
- Patients with spinal abnormalities
- Patients with bleeding abnormalities
- Patients who have undergone previous multiple abdominal surgeries
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site, 1 recruiting
- Recruiting
Children Hospital and Institute of Child Health Faisalabad
Faisalābad, Punjab Province
Naveed Irshad, MBBS, +92 334 0671331
About this study
Official title: Comparison of Outcome of Colostomy Reversal in Pediatric Patients With Enhanced Recovery After Surgery Versus Traditional Care Protocols.
The goal of this clinical trial is to learn whether using an Enhanced Recovery After Surgery (ERAS) protocol helps children recover faster after colostomy reversal compared with traditional care.
The main question it aims to answer is:
Read more
Does ERAS lower the number of days children need to stay in the hospital after colostomy reversal compared with traditional care?
Researchers will compare two groups:
ERAS group - Children receive shorter pre-surgery fasting, no mechanical bowel preparation, early pain control, and early feeding after surgery.
Traditional care group - Children receive the usual long bowel preparation, overnight fasting, opioid pain medicine, and a longer period without food after surgery.
Participants will:
Be randomly assigned to either the ERAS or traditional care group
Have their colostomy surgically closed by experienced pediatric surgeons
Be monitored daily until they can eat a solid meal without vomiting; this marks the end of their hospital stay
The study will enroll 60 children ages 2-13 at Children's Hospital Faisalabad, Pakistan.
Researchers will measure length of hospital stay from surgery until discharge as the main outcome.
Read the detailed description
This single-center, prospective randomized controlled trial will compare two perioperative care strategies for pediatric colostomy reversal: the Enhanced Recovery After Surgery (ERAS) protocol and the conventional Traditional Care Protocol (TCP). The study is being conducted in the Department of Pediatric Surgery at the Children's Hospital and Institute of Child Health, Faisalabad, Pakistan.
Scientific Rationale
Colostomy reversal restores bowel continuity after temporary fecal diversion, which is frequently performed in children with anorectal malformations (ARM), Hirschsprung's disease (HD), or following severe perineal injury. Conventional postoperative care has historically included three days of mechanical bowel preparation, prolonged pre-operative fasting, routine nasogastric decompression, opioid-based analgesia, and delayed oral feeding. Evidence from both adult and pediatric literature shows that ERAS protocols-emphasizing minimal bowel preparation, shortened fasting, multimodal non-opioid analgesia, and early enteral feeding-can reduce hospital stay and enhance recovery without increasing complications. However, high-quality pediatric data, especially from South Asia, remain limited.
Study Design
The trial will enroll 60 children (ages 2-13 years) who meet inclusion criteria and have no major comorbidities or prior extensive abdominal surgery. Using a computer-generated randomization table, participants will be allocated in a 1:1 ratio to either the ERAS or TCP arm. The allocation will occur after informed consent from parents or guardians.
ERAS arm:
Pre-operative preparation consists of two rectal enemas and oral laxative 12 hours apart on the day before surgery.
Clear oral fluids are allowed until three hours prior to anesthesia.
Intraoperative management includes minimal bowel handling and caudal block for pain control.
Postoperative care features avoidance of opioid analgesia, removal of nasogastric tube within 48 hours, and initiation of clear oral fluids followed by early progression to solid diet as tolerated.
Traditional Care arm:
Mechanical bowel preparation and clear fluid diet for three days before surgery.
Overnight fasting and intra-venous antibiotics are given.
Postoperative management includes routine nasogastric decompression with a nil-per-mouth regimen for at least three days, opioid analgesia, and gradual reintroduction of oral intake starting on postoperative day three or four.
All operations will be performed by consultant pediatric surgeons with at least five years of post-FCPS experience to ensure procedural consistency.
Data Collection and Analysis
Daily postoperative assessments will include vital signs, abdominal examination, and tolerance of oral intake. Laboratory evaluation on postoperative day one will include complete blood count and serum electrolytes, with corrections as indicated. The primary endpoint is length of hospital stay, defined as the number of days from surgery to discharge once the child consumes at least one age-appropriate solid meal without vomiting for six hours. Data will be entered in SPSS version 25. Quantitative variables will be summarized as means and standard deviations; qualitative variables as frequencies and percentages. Independent-sample t tests will compare the primary outcome between groups. Age, gender, and underlying diagnosis will be assessed as potential effect modifiers through stratification followed by post-stratification t tests. A p-value ≤0.05 will be considered statistically significant.
Significance
This study addresses a key evidence gap by providing randomized controlled data on ERAS in a high-volume pediatric surgical setting in Punjab, Pakistan. Demonstrating a reduction in hospital stay without added complications could support broader adoption of ERAS protocols, improving patient turnover, reducing healthcare costs, and enhancing recovery for children undergoing colostomy reversal.
- Conditions
- Colostomy - Stoma, Stoma Reversal Procedure, ERAS
- Being tested
- Enhanced Recovery after Surgery Protocol, Traditional Care Protocol
- Keywords
- Pediatric Colostomy, Colostomy Reversal, Enhanced Recovery After Surgery, ERAS, Traditional Care protocol, Length of Hospital Stay
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Enhanced Recovery after Surgery ProtocolOther
Also called ERAS
reduced fasting, no mechanical bowel prep, early feeding, non-opioid analgesia.
Traditional Care ProtocolOther
Participants receive standard peri-operative management for colostomy reversal. This includes three days of mechanical bowel preparation with oral laxatives and clear fluids, overnight fasting before surgery, routine nasogastric tube placement, opioid-based postoperative pain control, and a nil-per-mouth regimen for at least three days after surgery before gradually resuming oral intake.
| Study group | Role | What they receive |
|---|---|---|
| Enhanced Recovery after Surgery (ERAS) | Experimental | Patients undergoing colostomy reversal managed with the Enhanced Recovery After Surgery (ERAS) protocol, which emphasizes reduced fasting, avoidance of mechanical bowel preparation, early postoperative oral feeding, and multimodal non-opioid analgesia. Receives: Other: Enhanced Recovery after Surgery Protocol |
| Traditional Care Protocol | Active comparator | Patients undergoing colostomy reversal managed with the traditional perioperative care protocol, including three days of mechanical bowel preparation, overnight fasting before surgery, routine nasogastric tube placement, opioid-based postoperative pain control, and delayed resumption of oral intake. Receives: Other: Traditional Care Protocol |
What is being measured
The primary outcome is the main question the study is designed to answer.
Length of Hospital Stay (Days)
Duration of hospitalization measured from the day of surgery until discharge.
Measured: From date of surgery through hospital discharge (an average of 3-14 days)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Oct 2025
- Study start1 Aug 2025
- Primary completionNov 2025 (estimated)
- Study completionNov 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Colostomy - StomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Children Hospital Faisalabad
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Salman Ali, Children Hospital Faisalabad
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07206836
- Sponsor's protocol ID
- 696/CH&ICH/FSD
- Status last verified
- Sep 2025
- First submitted
- 13 Sep 2025
- Last updated
- 3 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Age, Gender, Diagnosis, Arm of study, Length of Hospital Stay
Study at a glance
From the registry record, last updated by the sponsor on 3 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Outcome of Colostomy Reversal in Pediatric Patients With Enhanced Recovery After Surgery Versus Traditional Care Protocols.
- ClinicalTrials.gov ID
- NCT07206836
- Acronym / sponsor ID
- 696/CH&ICH/FSD
- Conditions
- Colostomy - Stoma, Stoma Reversal Procedure, ERAS
- Keywords
- Pediatric Colostomy, Colostomy Reversal, Enhanced Recovery After Surgery, ERAS, Traditional Care protocol, Length of Hospital Stay
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Children Hospital FaisalabadUniversity, hospital or other
- Study start
- 1 Aug 2025 (actual)
- Primary completion
- Nov 2025 (estimated)
- Study completion
- Nov 2025 (estimated)
- First posted
- 3 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn whether using an Enhanced Recovery After Surgery (ERAS) protocol helps children recover faster after colostomy reversal compared with traditional care.
The main question it aims to answer is:
Does ERAS lower the number of days children need to stay in the hospital after colostomy reversal compared with traditional care?
Researchers will compare two groups:
ERAS group - Children receive shorter pre-surgery fasting, no mechanical bowel preparation, early pain control, and early feeding after surgery.
Traditional care group - Children receive the usual long bowel preparation, overnight fasting, opioid pain medicine, and a longer period without food after surgery.
Participants will:
Be randomly assigned to either the ERAS or traditional care group
Have their colostomy surgically closed by experienced pediatric surgeons
Be monitored daily until they can eat a solid meal without vomiting; this marks the end of their hospital stay
The study will enroll 60 children ages 2-13 at Children's Hospital Faisalabad, Pakistan.
Researchers will measure length of hospital stay from surgery until discharge as the main outcome.
Detailed description
This single-center, prospective randomized controlled trial will compare two perioperative care strategies for pediatric colostomy reversal: the Enhanced Recovery After Surgery (ERAS) protocol and the conventional Traditional Care Protocol (TCP). The study is being conducted in the Department of Pediatric Surgery at the Children's Hospital and Institute of Child Health, Faisalabad, Pakistan.
Scientific Rationale
Colostomy reversal restores bowel continuity after temporary fecal diversion, which is frequently performed in children with anorectal malformations (ARM), Hirschsprung's disease (HD), or following severe perineal injury. Conventional postoperative care has historically included three days of mechanical bowel preparation, prolonged pre-operative fasting, routine nasogastric decompression, opioid-based analgesia, and delayed oral feeding. Evidence from both adult and pediatric literature shows that ERAS protocols-emphasizing minimal bowel preparation, shortened fasting, multimodal non-opioid analgesia, and early enteral feeding-can reduce hospital stay and enhance recovery without increasing complications. However, high-quality pediatric data, especially from South Asia, remain limited.
Study Design
The trial will enroll 60 children (ages 2-13 years) who meet inclusion criteria and have no major comorbidities or prior extensive abdominal surgery. Using a computer-generated randomization table, participants will be allocated in a 1:1 ratio to either the ERAS or TCP arm. The allocation will occur after informed consent from parents or guardians.
ERAS arm:
Pre-operative preparation consists of two rectal enemas and oral laxative 12 hours apart on the day before surgery.
Clear oral fluids are allowed until three hours prior to anesthesia.
Intraoperative management includes minimal bowel handling and caudal block for pain control.
Postoperative care features avoidance of opioid analgesia, removal of nasogastric tube within 48 hours, and initiation of clear oral fluids followed by early progression to solid diet as tolerated.
Traditional Care arm:
Mechanical bowel preparation and clear fluid diet for three days before surgery.
Overnight fasting and intra-venous antibiotics are given.
Postoperative management includes routine nasogastric decompression with a nil-per-mouth regimen for at least three days, opioid analgesia, and gradual reintroduction of oral intake starting on postoperative day three or four.
All operations will be performed by consultant pediatric surgeons with at least five years of post-FCPS experience to ensure procedural consistency.
Data Collection and Analysis
Daily postoperative assessments will include vital signs, abdominal examination, and tolerance of oral intake. Laboratory evaluation on postoperative day one will include complete blood count and serum electrolytes, with corrections as indicated. The primary endpoint is length of hospital stay, defined as the number of days from surgery to discharge once the child consumes at least one age-appropriate solid meal without vomiting for six hours. Data will be entered in SPSS version 25. Quantitative variables will be summarized as means and standard deviations; qualitative variables as frequencies and percentages. Independent-sample t tests will compare the primary outcome between groups. Age, gender, and underlying diagnosis will be assessed as potential effect modifiers through stratification followed by post-stratification t tests. A p-value ≤0.05 will be considered statistically significant.
Significance
This study addresses a key evidence gap by providing randomized controlled data on ERAS in a high-volume pediatric surgical setting in Punjab, Pakistan. Demonstrating a reduction in hospital stay without added complications could support broader adoption of ERAS protocols, improving patient turnover, reducing healthcare costs, and enhancing recovery for children undergoing colostomy reversal.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Enhanced Recovery after Surgery (ERAS) | Experimental | Other: Enhanced Recovery after Surgery ProtocolPatients undergoing colostomy reversal managed with the Enhanced Recovery After Surgery (ERAS) protocol, which emphasizes reduced fasting, avoidance of mechanical bowel preparation, early postoperative oral feeding, and multimodal non-opioid analgesia. |
| Traditional Care Protocol | Active comparator | Other: Traditional Care ProtocolPatients undergoing colostomy reversal managed with the traditional perioperative care protocol, including three days of mechanical bowel preparation, overnight fasting before surgery, routine nasogastric tube placement, opioid-based postoperative pain control, and delayed resumption of oral intake. |
Who may qualify
- Ages
- 2 to 13 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (2 listed)
- Patients with Colostomy
- Admitted for Reversal of colostomy
Key exclusion criteria (5 listed)
- Patients with endocrinal abnormalities
- Patients with cardiac abnormalities
- Patients with spinal abnormalities
- Patients with bleeding abnormalities
- Patients who have undergone previous multiple abdominal surgeries
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Enhanced Recovery after Surgery ProtocolAlso: ERASreduced fasting, no mechanical bowel prep, early feeding, non-opioid analgesia. | Other | Enhanced Recovery after Surgery (ERAS) |
| Traditional Care ProtocolParticipants receive standard peri-operative management for colostomy reversal. This includes three days of mechanical bowel preparation with oral laxatives and clear fluids, overnight fasting before surgery, routine nasogastric tube placement, opioid-based postoperative pain control, and a nil-per-mouth regimen for at least three days after surgery before gradually resuming oral intake. | Other | Traditional Care Protocol |
Primary outcome
Length of Hospital Stay (Days)
Time frame: From date of surgery through hospital discharge (an average of 3-14 days)
Duration of hospitalization measured from the day of surgery until discharge.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Oct 2025.
- Individual participant dataSharing planned: Yes. Age, Gender, Diagnosis, Arm of study, Length of Hospital Stay
Related trials for Colostomy - Stoma
RecruitingObservational study
Parastomal Hernia at 1 and 3 Years: Radiological Incidence, Progression, and Impact on Quality of Life
Parastomal Hernia, Colorectal Cancer (Diagnosis)
Not yet recruiting
Suture Choice for Ostomy Creation
Ostomy - Ileostomy or Colostomy, Stoma Complications
Active, not recruiting
The Effect of Planned Group Interaction on Ostomy Adaptation, Quality of Life, and Stoma Care Self-Efficacy Levels in Individuals With an Ostomy
Ostomy - Ileostomy or Colostomy
RecruitingObservational study
Exploratory Study of Peristomal and Non-Peristomal Skin Barrier Characteristics in People With a Stoma
Colostomy - Stoma, Ileostomy - Stoma
Active, not recruiting
Impact of Resilience Training on Quality of Life in New Ostomy Patients and Their Partners
Ileostomy - Stoma, Colostomy - Stoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Enhanced Recovery after Surgery Protocol and Traditional Care Protocol in people with Colostomy - Stoma and Stoma Reversal Procedure, run by Children Hospital Faisalabad at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Salman Ali, MBBS (+923000680882, SalmanAli@live.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Length of Hospital Stay (Days) (time frame: From date of surgery through hospital discharge (an average of 3-14 days)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2025.